Matthew Angel Insider Trading

Name: Matthew Angel insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 23, 2026): Purchase of 231,482 TPST shares, $500.0K.

Get alerted when insiders trade TPST

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Filed	Company	Transaction	Shares	Value
Jun 23, 2026	Tempest Therapeutics, Inc. (TPST)	Purchase	231,482	$500.0K
Mar 25, 2026	Tempest Therapeutics, Inc. (TPST)	Purchase	231,482	$500.0K
Feb 6, 2026	Tempest Therapeutics, Inc. (TPST)	Grant/Award	269,621	n/a
Jan 13, 2023	Eterna Therapeutics Inc. (ERNA)	Grant/Award	132,003	n/a
Aug 3, 2022	Brooklyn ImmunoTherapeutics, Inc. (BTX)	Grant/Award	2,487,003	n/a

Loading insider data...